Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Trichuris incognita Species with Low Sensitivity to Albendazole/Ivermectin Combination Treatment

Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Trichuris incognita Species with Low Sensitivity to Albendazole/Ivermectin Combination Treatment

Albendazole/ivermectin combination therapy is a promising alternative to benzimidazole monotherapy alone for Trichuris trichiura control. We used fecal DNA metabarcoding to genetically characterize Trichuris spp. populations in patient samples from Côte d’Ivoire showing lower (egg reduction rate &l...

Full description

Saved in:
Bibliographic Details
Main Authors: Abhinaya Venkatesan, Rebecca Chen, Max Bär, Pierre H.H. Schneeberger, Brenna Reimer, Eveline Hürlimann, Jean T. Coulibaly, Said M. Ali, Somphou Sayasone, John Soghigian, Jennifer Keiser, John Stuart Gilleard
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2025-01-01
Series:Emerging Infectious Diseases
Subjects:
trichuriasis
Trichuris incognita
whipworm
helminthiasis
albendazole
ivermectin
Online Access:https://wwwnc.cdc.gov/eid/article/31/1/24-0995_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://wwwnc.cdc.gov/eid/article/31/1/24-0995_article

Similar Items